Apremilast With Add-On Calcipotriene/Betamethasone Dipropionate for Treating Moderate to Severe Plaque Psoriasis

Bagel Jerry; Nelson Elise; Riley Cheryl; Hetzel Alexa

首页> 外文期刊>Journal of drugs in dermatology: JDD >Apremilast With Add-On Calcipotriene/Betamethasone Dipropionate for Treating Moderate to Severe Plaque Psoriasis

【24h】

Apremilast With Add-On Calcipotriene/Betamethasone Dipropionate for Treating Moderate to Severe Plaque Psoriasis

机译：Apremilast与加入的Calcipotriene / Betamhisonoone双丙酸盐治疗中度至重度斑块牛皮癣

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: About 20% of patients taking apremilast alone obtain PASI 75 by week 8. This single-center, pilot study aimed to determine whether add-on topical therapy with calcipotriene/betamethasone dipropionate (C/BD) could improve responses of partial apremilast responders by week 12.

机译：背景：大约20%单独服用阿普瑞司特的患者在第8周获得PASI 75。这项单中心试点研究的目的是确定在第12周之前，加用钙泊三烯/二丙酸倍他米松（C/BD）局部治疗是否可以改善部分阿普瑞司特应答者的反应。

著录项

来源
《Journal of drugs in dermatology: JDD》 |2020年第12期|共7页
作者
Bagel Jerry; Nelson Elise; Riley Cheryl; Hetzel Alexa;
展开▼
作者单位

Psoriasis Treatment Ctr Cent New Jersey East Windsor NJ 08520 USA;

Psoriasis Treatment Ctr Cent New Jersey East Windsor NJ 08520 USA;

Psoriasis Treatment Ctr Cent New Jersey East Windsor NJ 08520 USA;

Psoriasis Treatment Ctr Cent New Jersey East Windsor NJ 08520 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. Efficacy and safety of secukinumab in Chinese patients with moderate-to-severe plaque psoriasis:a real-life cohort study [J] . Yan Zhao, Lin Cai, Xiao-Yang Liu, 中华医学杂志（英文版） . 2021,第011期
2. Secukinumab demonstrates high efficacy and a favorable safety profile over 52 weeks in Chinese patients with moderate to severe plaque psoriasis [J] . Lin Cai, Hao Cheng, Qing Guo, 中华医学杂志（英文版） . 2020,第022期
3. Infliximab monotherapy for Chinese patients with moderate to severe plaque psoriasis: a randomized, double-blind,placebo-controlled multicenter trial [J] . YANG Hai-zhen, LIU Xiao-ming, TU Cai-xia, 中华医学杂志（英文版） . 2012,第011期
4. Efficacy and Safety of Calcipotriene 0.005%/Betamethasone Dipropionate 0.064% Foam With Apremilast for Moderate Plaque Psoriasis [J] . Kircik Leon H., Schlesinger Todd E., Tanghetti Emil Journal of drugs in dermatology: JDD . 2020,第9期

机译：Calcipotriene的功效和安全性0.005％/倍络塞酮二丙酸0.064％泡沫，适用于适度的斑块牛皮癣
5. Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial. [J] . Kircik LH Journal of drugs in dermatology: JDD . 2011,第8期

机译：在中度至重度斑块状牛皮癣患者中，降压后局部用卡泊三烯0.005％和倍他米松二丙酸酯0.064％维持依那西普的疗效：一项开放性试验的结果。
6. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis. [J] . Menter A, Abramovits W, Colon LE, Journal of drugs in dermatology: JDD . 2009,第1期

机译：将0.05％丙酸氯倍他索喷雾剂与卡泊三烯0.005％倍他米松双丙酸酯0.064％软膏剂进行比较，以治疗中度至重度斑块状牛皮癣。
7. Novel Loss Circulation Composition to Treat Moderate to Severe Losses [C] . Vikrant Wagle, Rajendra Kalgaonkar, Abdullah AlYami SPE Oil and Gas India Conference and Exhibition . 2019

机译：新型损失循环组合物治疗中度至严重损失
8. Plaque-Type Psoriasis Treated with Calcipotriene Plus Betamethasone Dipropionate Aerosol Foam: A Prospective Study on Clinical and Dermoscopic Predictor Factors in Response Achievement and Retention [O] . Enzo Errichetti, Margherita Croatto, Luca Arnoldo, 2020

机译：Calcipotriene联合倍他米松双丙酸酯气雾剂泡沫治疗的斑块型牛皮癣：反应和保持的临床和皮肤镜预测因素的前瞻性研究
9. Twice-weekly topical calcipotriene/betamethasone dipropionate foam as proactive management of plaque psoriasis increases time in remission and is well tolerated over 52 weeks (PSO-LONG trial) [O] . Mark Lebwohl, Leon Kircik, Jean-Philippe Lacour, 2021

机译：两次局部局部求生丙烯/倍络塞酮二丙酸盐泡沫作为斑块牛皮癣的主动管理增加了缓解时间，并且在52周（PSO长试，耐受良好的耐受性）

Apremilast With Add-On Calcipotriene/Betamethasone Dipropionate for Treating Moderate to Severe Plaque Psoriasis

摘要

著录项

相似文献

相关主题

期刊订阅